Matthew M. Walsh - 20 Feb 2025 Form 4 Insider Report for Organon & Co. (OGN)

Role
Chief Financial Officer
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Matthew M. Walsh
Issuer symbol
OGN
Transactions as of
20 Feb 2025
Net transactions value
-$188,250
Form type
4
Filing time
24 Feb 2025, 17:09:12 UTC
Previous filing
05 Sep 2024
Next filing
02 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Award $0 +30,414 +33% $0.000000 122,388 20 Feb 2025 Direct F1
transaction OGN Common Stock Tax liability $159,077 -10,662 -8.7% $14.92 111,726 20 Feb 2025 Direct
transaction OGN Common Stock Award $0 +5,570 +5% $0.000000 117,296 20 Feb 2025 Direct F2
transaction OGN Common Stock Tax liability $29,173 -1,908 -1.6% $15.29 115,388 20 Feb 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Organon & Co. common stock ("Common Stock") for performance share units ("PSUs") granted to the reporting person on August 09, 2022 under the Organon & Co. 2021 Incentive Stock Plan. The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of Directors.
F2 Represents the shares of Common Stock released to cover the dividend equivalents earned on the PSUs released above.